Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.

Wilczek, H E; Akesson, P; Warholm, C

Wilczek, H E; Akesson, P; Warholm, C.

Affiliation

Wilczek HE; Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.

Transplant Proc ; 30(5): 1753-5, 1998 Aug.

Article in En | MEDLINE | ID: mdl-9723267

Subject(s)

Cyclosporine/blood; Cyclosporine/therapeutic use; Immunosuppressive Agents/therapeutic use; Kidney Transplantation/immunology; Administration, Oral; Adult; Aged; Antihypertensive Agents/therapeutic use; Blood Pressure/drug effects; Creatinine/blood; Cyclosporine/administration & dosage; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunosuppressive Agents/administration & dosage; Immunosuppressive Agents/blood; Kidney Transplantation/physiology; Male; Middle Aged; Retrospective Studies; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Cyclosporine / Immunosuppressive Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 1998 Document type: Article Affiliation country: Sweden

Search on Google

Add to My VHL

XML

PubMed Links